Advertisement

Primary Prevention of Myocardial Infarction: Putting the Evidence to Use: Comment on "Medication in Relation to ST-Segment Elevation Myocardial Infarction in Patients With a First Myocardial Infarction".

03:37 EDT 18th June 2013 | BioPortfolio

Summary of "Primary Prevention of Myocardial Infarction: Putting the Evidence to Use: Comment on "Medication in Relation to ST-Segment Elevation Myocardial Infarction in Patients With a First Myocardial Infarction"."

No Summary Available

Affiliation

Cardiac Care Unit, St Luke's-Roosevelt Hospital Center, Clinical Medicine, Columbia University College of Physicians and Surgeons, 1111 Amsterdam Ave, New York, NY 10025. eherzog@chpnet.org.

Journal Details

This article was published in the following journal.

Name: Archives of internal medicine
ISSN: 1538-3679
Pages: 1381-2

Links

Medical and Biotech [MESH] Definitions

Anterior Wall Myocardial Infarction

MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.

Primary Prevention

Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.

Inferior Wall Myocardial Infarction

MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.

Heart Rupture, Post-infarction

Laceration or tearing of cardiac tissues appearing after MYOCARDIAL INFARCTION.

Medication Therapy Management

Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.

PubMed Articles [ 19806 Associated PubMed Articles listed on BioPortfolio]

Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.

Aspirin is effective for the prevention of cardiovascular events in patients with a history of vascular disease, as so-called secondary prevention. In general populations with no history of previous m...

Cardioprotection in the Clinical Setting-Lessons from J-WIND Studies.

INTRODUCTION: Both prevention and attenuation of ischemic heart disease are important issues, and there are three different strategies to save patients from the deleterious sequelae of ischemic injury...

Letter by fresco regarding article "primary angioplasty versus fibrinolysis in acute myocardial infarction: long-term follow-up in the danish acute myocardial infarction 2 trial".

Outcome Comparison of 600- and 300-mg Loading Doses of Clopidogrel in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Results From the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocard

The purpose of this study was to compare 600- and 300-mg clopidogrel loading doses in patients with ST-segment elevation myocardial infarction (STEMI).

Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Myocardial necrosis is a time-dependent event. Nevertheless, clinical studies on association between ischemic time and left ventricle function showed inconsistent findings. Aim of current study is to...

Clinical Trials [ 4956 Associated Clinical Trials listed on BioPortfolio]

IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction

Of the patients who survive hospitalization after an acute myocardial infarction, ca. 10% die of sudden cardiac death in the following 2 years. The prognosis appears not improved by medica...

Sirolimus Eluting Stenting in Acute Myocardial Infarction

The incidence of stent restenosis in the setting of primary angioplasty is particularly high, reaching a rate of 27% In the last years the introduction of drug-eluting stents has drast...

Pilot Study of Edaravone to Treat Acute Myocardial Infarction

Early reperfusion therapy has improved the clinical outcomes of patients with acute myocardial infarction (AMI), but these benefits are limited in some patients by reperfusion injuries. T...

ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI)

Of estimated 140,000 cases of acute myocardial infarction admitted to hospitals in Germany per year, approximately 50% present with Non-ST-elevation myocardial infarction (NSTEMI). The cur...

Feasibility of High Frequency QRS Analysis in Patients With Acute Myocardial Infarction

The primary objective of this study is to characterize the morphological patterns of high frequency QRS components (HFQRS) in patients with acute myocardial infarction (AMI), including STE...

Search BioPortfolio:
Advertisement
Advertisement

Latest Biotech, Pharma and Healthcare News

No significant difference in the risk of Acute Coronary Syndrome (including Myocardial Infarction) seen with Pradaxa® (dabigatran etexilate) compared to enoxaparin for VTE prevention after orthopaedic surgery

STENTYS Clinical Study Demonstrating Superiority of Self-Apposing® Stents Over Conventional Stents Published in American College of Cardiology Journal

Miracor Granted Five Additional U.S. Patents and One Additional European Patent for Its PICSO® System to Treat Severe Heart Attack Patients

Miracor Successfully Completes First German Patient Using the PICSO® System to Treat Severe Heart Attack Patients Post-Primary PCI

Santarus and VeroScience Announce Publication of New Analysis of CYCLOSET (bromocriptine mesylate) Cardiovascular Data in the Journal of the American Heart Association

Miracor Medical System’s PICSO® System to Be Showcased at ‘OneMedForum San Francisco’ Investor Conference, January 9, 2013, 12:20 P.M. PST

Sleep Apnea Can Reduce Severity Of Cardiac Injury During A Heart Attack, According To Montefiore Study


Searches Linking to this Article